Abstract
—Plasminogen activator inhibitor (PAI)-1 is the main inhibitor of the fibrinolytic system and was recently shown to be produced by adipose cells. Obesity is associated with an increased production and release of PAI-1 protein. The aim of this study was to investigate the role of angiotensin (Ang) II and its degradation products for PAI-1 release from human adipose cells. For this purpose, we used the model of in vitro differentiated human adipocytes in primary culture. Exposure of human adipocytes to Ang II resulted in a dose- and time-dependent stimulation of PAI-1 release into the culture medium. The maximum effect of Ang II was found at a concentration of 10 −5 mol/L for 48 hours, increasing PAI-1 release by 276±53% compared with control cultures ( P P −5 mol/L Ang III and Ang IV, respectively, also resulted in a stimulation of PAI-1 release into the medium by 195±60% ( P P 1 ) blocker candesartan abolished the stimulatory action of Ang II and its metabolites, indicating that this effect is mediated by AT 1 . Addition of the AT 1 blocker alone to unstimulated cultures reduced PAI-1 release by 41%±25% ( P 1 receptor blockade reduces basal and abolishes Ang II–stimulated PAI-1 release from human adipocytes.

This publication has 21 references indexed in Scilit: